{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:46:55Z","timestamp":1788385615179,"version":"build-2803163510"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T00:00:00Z","timestamp":1654473600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.jconrel.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T18:06:56Z","timestamp":1655143616000},"page":"431-443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Contact lenses for pravastatin delivery to eye segments: Design and in vitro-in vivo correlations"],"prefix":"10.1016","volume":"348","author":[{"given":"Ana F.","family":"Pereira-da-Mota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Vivero-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Serramito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Diaz-Gomez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Paula","family":"Serro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Carracedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Huete-Toral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel","family":"Concheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Alvarez-Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2022.06.001_bb0005","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.survophthal.2019.01.013","article-title":"Statins in ophthalmology","volume":"64","author":"Ooi","year":"2019","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0020","first-page":"675","article-title":"Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema","volume":"137","author":"Gupta","year":"2004","journal-title":"Am J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0025","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1136\/bjo.2006.098285","article-title":"Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy","volume":"91","author":"Ozkiris","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0030","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12933-016-0486-2","article-title":"Association of statin use and hypertriglyceridemia with diabetic macular edema in patients with type 2 diabetes and diabetic retinopathy","volume":"16","author":"Chung","year":"2017","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0035","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(14)70173-1","article-title":"Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study","volume":"2","author":"Nielsen","year":"2014","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0040","author":"International Diabetes Federation"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4239\/wjd.v6.i1.92","article-title":"Ocular complications of diabetes mellitus","volume":"6","author":"Sayin","year":"2015","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0050","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ceo.12690","article-title":"Impact of diabetes mellitus on the ocular surface: a review","volume":"44","author":"Misra","year":"2016","journal-title":"Clin. Exp. Opthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0055","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/629452","article-title":"Therapeutic interventions against inflammatory and angiogenic mediators in proliferative diabetic retinopathy","volume":"2012","author":"Gologorsky","year":"2012","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0060","doi-asserted-by":"crossref","first-page":"16012","DOI":"10.1038\/nrdp.2016.12","article-title":"Diabetic retinopathy","volume":"2","author":"Wong","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0065","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1161\/01.CIR.0000034509.14906.AE","article-title":"Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress","volume":"106","author":"Esposito","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0070","doi-asserted-by":"crossref","first-page":"5906","DOI":"10.1167\/iovs.12-10410","article-title":"Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines","volume":"53","author":"Schoenberger","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0075","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/archopht.125.8.1096","article-title":"Association of statin use with the risk of developing diabetic retinopathy","volume":"125","author":"Zhang","year":"2007","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4239\/wjd.v8.i1.1","article-title":"Role of lipid-lowering agents in the management of diabetic retinopathy","volume":"8","author":"Ioannidou","year":"2017","journal-title":"World J. Diabetes"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0085","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.3390\/ijms21228745","article-title":"The role of structure and biophysical properties in the pleiotropic eects of statins","volume":"21","author":"Murphy","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000367851","article-title":"Efficacy and safety of topical atorvastatin for the treatment of dry eye associated with blepharitis: a pilot study","volume":"54","author":"Ooi","year":"2015","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0095","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1021\/ie0507934","article-title":"Modeling ophthalmic drug delivery by soaked contact lenses","volume":"45","author":"Li","year":"2006","journal-title":"Ind. Eng. Chem. Res."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0100","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s13346-018-0541-5","article-title":"Controlled delivery of pirfenidone through vitamin E-loaded contact lens ameliorates corneal inflammation","volume":"8","author":"Dixon","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0105","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1089\/jop.2020.0058","article-title":"Extended delivery of pirfenidone with novel, soft contact lenses in vitro and in vivo","volume":"37","author":"Wu","year":"2021","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0110","author":"Johnson & Johnson News"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119688","article-title":"Sustained delivery of epalrestat to the retina using PEGylated solid lipid nanoparticles laden contact lens","volume":"587","author":"Zhu","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0120","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/02713683.2015.1050738","article-title":"Hydrogel ring for topical drug delivery to the ocular posterior segment","volume":"41","author":"Shikamura","year":"2016","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0125","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.actbio.2019.01.004","article-title":"Effect of gold nanoparticles on timolol uptake and its release kinetics from contact lenses: in vitro and in vivo evaluation","volume":"86","author":"Maulvi","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.actbio.2018.11.020","article-title":"Bioinspired hydrogels for drug-eluting contact lenses","volume":"84","author":"Alvarez-Lorenzo","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0135","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1167\/iovs.12-10614","article-title":"Development and efficacy of a drug-releasing soft contact lens","volume":"54","author":"Kakisu","year":"2013","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0210362","article-title":"In vitro and in vivo performance of epinastine hydrochloride releasing contact lenses","volume":"14","author":"Minami","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0145","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jcis.2018.12.036","article-title":"Effect of vitamin-E integration on delivery of prostaglandin analogs from therapeutic lenses","volume":"539","author":"Sekar","year":"2019","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0150","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1167\/tvst.10.14.5","article-title":"Controlled release of multiple therapeutics from silicone hydrogel contact lenses for post-cataract\/post-refractive surgery and uveitis treatment","volume":"10","author":"DiPasquale","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0155","first-page":"2101263","article-title":"One week sustained in vivo therapeutic release and safety of novel extended-wear silicone hydrogel contact lenses","author":"DiPasquale","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/pharmaceutics13010036","article-title":"Therapeutic ophthalmic lenses: a review","volume":"13","author":"Toffoletto","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.clae.2014.04.005","article-title":"Analysis of release kinetics of ocular therapeutics from drug releasing contact lenses: best methods and practices to advance the field","volume":"37","author":"Tieppo","year":"2014","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0170","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.clae.2015.07.007","article-title":"Structural design of contact lens-based drug delivery systems; in vitro and in vivo studies of ocular triggering mechanisms","volume":"39","author":"Mahomed","year":"2016","journal-title":"Cont. Lens Anterior Eye"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1002\/jbm.b.33715","article-title":"Drug release from liposome coated hydrogels for soft contact lenses: the blinking and temperature effect","volume":"105B","author":"Paradiso","year":"2017","journal-title":"J. Biomed. Mater. Res. B"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0180","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3390\/pharmaceutics13030300","article-title":"Development of an in vitro blink model for ophthalmic drug delivery","volume":"13","author":"Phan","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0185","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/OPX.0000000000000809","article-title":"In vivo studies evaluating the use of contact lenses for drug delivery","volume":"93","author":"Hui","year":"2016","journal-title":"Optom. Vis. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jconrel.2022.02.014","article-title":"Testing drug release from medicated contact lenses: the missing link to predict in vivo performance","volume":"343","author":"Pereira-da-Mota","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0195","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/pharmaceutics13050606","article-title":"Atorvastatin-eluting contact lenses: effects of molecular imprinting and sterilization on drug loading and release","volume":"13","author":"Pereira-da-Mota","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0200","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1016\/j.bmc.2007.04.031","article-title":"The biology and chemistry of hyperlipidemia","volume":"15","author":"Jain","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0205","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/jps.10209","article-title":"Soft contact lenses capable of sustained delivery of timolol","volume":"91","author":"Alvarez-Lorenzo","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0210","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/ICL.0000000000000442","article-title":"Mechanical properties of contact lens materials","volume":"44","author":"Kim","year":"2018","journal-title":"Eye Contact Lens"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1015887213431","article-title":"Hydrogels: swelling, drug loading, and release","volume":"9","author":"Kim","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110092","article-title":"Hydrogels for diabetic eyes: naltrexone loading, release profiles and cornea penetration","volume":"105","author":"Alvarez-Rivera","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0225","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2014.08.002","article-title":"THP-1 cell line: An in vitro cell model for immune modulation approach","volume":"23","author":"Chanput","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0230","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1039\/C9BM01582E","article-title":"Cytosine-functionalized bioinspired hydrogels for ocular delivery of antioxidant transferulic acid","volume":"8","author":"Varela-Garcia","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0235","doi-asserted-by":"crossref","first-page":"462","DOI":"10.21037\/atm-21-97","article-title":"Bicarbonate Ringer\u2019s solution for early resuscitation in hemorrhagic shock rabbits","volume":"9","author":"Wang","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0240","doi-asserted-by":"crossref","first-page":"687","DOI":"10.4103\/0250-474X.59555","article-title":"Entrapment of ketorolac tromethamine in polymeric vehicle for controlled drug delivery","volume":"71","author":"Paliwal","year":"2009","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0245","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1365\/s10337-006-0843-5","article-title":"Development of a selective LC method for the determination of pravastatin sodium","volume":"64","author":"Onal","year":"2006","journal-title":"Chromatogr."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0250","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ijpharm.2015.08.096","article-title":"Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment","volume":"495","author":"Al-Ghabeish","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0255","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijpharm.2018.09.053","article-title":"Soluplus micelles for acyclovir ocular delivery: formulation and cornea and sclera permeability","volume":"552","author":"Varela-Garcia","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0260","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1001\/archopht.1969.00990020012003","article-title":"Diagnostic tests in the sicca syndrome","volume":"82","author":"van Bijsterveld","year":"1969","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0265","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.biomaterials.2004.04.030","article-title":"Ocular release of timolol from molecularly imprinted soft contact lenses","volume":"26","author":"Hiratani","year":"2005","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0270","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/mol.64.4.785","article-title":"Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules","volume":"64","author":"Lazarowski","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0275","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jconrel.2019.05.025","article-title":"Co-delivery of latanoprost and timolol from micelles-laden contact lenses for the treatment of glaucoma","volume":"305","author":"Xu","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0280","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0285","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.memsci.2012.01.039","article-title":"Ion transport in silicone hydrogel contact lenses","volume":"399-400","author":"Peng","year":"2012","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.memsci.2013.10.010","article-title":"Oxygen and ionic transport in hidrogel and silicone-hydrogel contact lens materials: an experimental and theoretical study","volume":"452","author":"Pozuelo","year":"2014","journal-title":"J. Membr. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0295","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3390\/ma12020261","article-title":"Contact lens materials: a materials science perspective","volume":"12","author":"Musgrave","year":"2019","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0300","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1021\/bm101562v","article-title":"Bioinspired imprinted pHEMA-hydrogels for ocular delivery of carbonic anhydrase inhibitor drugs","volume":"12","author":"Ribeiro","year":"2011","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0305","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jconrel.2011.09.087","article-title":"Sustained in vivo release from imprinted therapeutic contact lenses","volume":"157","author":"Tieppo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0310","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0109-5641(94)90025-6","article-title":"Effect of cell line on in vitro metal ion cytotoxicity","volume":"10","author":"Wataha","year":"1994","journal-title":"Dent. Mater."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0315","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1254\/jphs.08238FP","article-title":"Possible mechanisms underlying statin-induced skeletal muscle toxicity in L6 fibroblasts and in rats","volume":"109","author":"Itagaki","year":"2009","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0320","author":"ISO 10993-5"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0325","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/10915810802656996","article-title":"Hen egg chorioallantoic membrane bioassay: an in vitro alternative to draize eye irritation test for pesticide screening","volume":"27","author":"Kishore","year":"2008","journal-title":"Int. J. Toxicol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4067\/S0717-97072008000400010","article-title":"Stability study of pravastatin under hydrolytic conditions assessed by HPLC","volume":"53","author":"Brain-Isasi","year":"2008","journal-title":"J. Chil. Chem. Soc."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0335","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1556\/AChrom.23.2011.1.8","article-title":"A validated stability-indicating method for simultaneous analysis of mevastatin and pravastatin in fermentation broth during bioconversion by Actinomadura macra","volume":"23","author":"Ahmad","year":"2011","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0340","doi-asserted-by":"crossref","first-page":"15","DOI":"10.14227\/DT180311P15","article-title":"Simulated biological fluids with possible application in dissolution testing","volume":"18","author":"Marques","year":"2011","journal-title":"Dissol. Technol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0345","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.carbpol.2011.03.042","article-title":"Synergistic performance of cyclodextrin-agar hydrogels for ciprofloxacin delivery and antimicrobial effect","volume":"85","author":"Blanco-Fern\u00e1ndez","year":"2011","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0350","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/psp4.12283","article-title":"Prediction of the pharmacokinetics of pravastatin as an OATP substrate using plateable human hepatocytes with human plasma data and PBPK modeling","volume":"7","author":"Mao","year":"2018","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0355","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1167\/tvst.5.6.3","article-title":"Release of moxifloxacin from contact lenses using an in vitro eye model: impact of artificial tear fluid composition and mechanical rubbing","volume":"5","author":"Phan","year":"2016","journal-title":"TVST"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0360","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jcis.2003.11.031","article-title":"Experimental study of albumin and lysozyme adsorption onto acrylic acid (AA) and 2-hydroxyethyl methacrylate (HEMA) surfaces","volume":"271","author":"Moradi","year":"2004","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0365","doi-asserted-by":"crossref","first-page":"6978","DOI":"10.1039\/c3sm50220a","article-title":"Understanding and modulating the competitive surface-adsorption of proteins through coarse-grained molecular dynamics simulations","volume":"9","author":"Vilaseca","year":"2013","journal-title":"Soft Matter"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0370","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.drudis.2019.02.001","article-title":"Design principles of ocular drug delivery systems: importance of drug payload, release rate, and material properties","volume":"24","author":"Subrizi","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0375","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.clim.2005.06.014","article-title":"In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells","volume":"117","author":"Bessler","year":"2005","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0380","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1582-4934.2010.01036.x","article-title":"Statins potently reduce the cytokine-mediated IL-6 release in SMC\/MNC cocultures","volume":"15","author":"Loppnow","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0385","doi-asserted-by":"crossref","first-page":"2582745","DOI":"10.1155\/2017\/2582745","article-title":"Statins reduce lipopolysaccharide-induced cytokine and inflammatory mediator release in an in vitro model of microglial-like cells","volume":"2017","author":"McFarland","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0390","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jconrel.2016.02.012","article-title":"In vitro and in vivo evaluation of novel implantation technology in hydrogel contact lenses for controlled drug delivery","volume":"226","author":"Maulvi","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2022.06.001_bb0395","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1163\/156856209X415774","article-title":"Preparation and evaluation of a contact lens vehicle for puerarin delivery","volume":"21","author":"Xu","year":"2010","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0400","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1089\/jop.1995.11.297","article-title":"The effect of the low blink rate in rabbits on topical drug penetration","volume":"11","author":"Maurice","year":"1995","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2022.06.001_bb0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/09205063.2014.994948","article-title":"About the effect of eye blinking on drug release from pHEMA-based hydrogels: an in vitro study","volume":"26","author":"Galante","year":"2015","journal-title":"J. Biomater. Sci. Polym. Ed."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365922003303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:30:46Z","timestamp":1759163446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365922003303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":81,"alternative-id":["S0168365922003303"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.001","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contact lenses for pravastatin delivery to eye segments: Design and in vitro-in vivo correlations","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}